上睑下垂
炎症
缺血
再灌注损伤
小胶质细胞
促炎细胞因子
内生
病变
炎症体
细胞生物学
神经科学
癌症研究
生物
医学
免疫学
病理
内科学
作者
Peixing Wan,Wenru Su,Yingying Zhang,Zhidong Li,Caibin Deng,Jinmiao Li,Nan Jiang,Siyu Huang,Erping Long,Yehong Zhuo
标识
DOI:10.1038/s41418-019-0351-4
摘要
Abstract Ischemia-reperfusion (I/R) is a common pathology when the blood supply to an organ was disrupted and then restored. During the reperfusion process, inflammation and tissue injury were triggered, which were mediated by immunocytes and cytokines. However, the mechanisms initiating I/R-induced inflammation and driving immunocytes activation remained largely unknown. In this study, we identified long non-coding RNA (lncRNA)-H19 as the key onset of I/R-induced inflammation. We found that I/R increased lncRNA-H19 expression to significantly promote NLRP3/6 inflammasome imbalance and resulted in microglial pyroptosis, cytokines overproduction, and neuronal death. These damages were effectively inhibited by lncRNA-H19 knockout. Specifically, lncRNA-H19 functioned via sponging miR-21 to facilitate PDCD4 expression and formed a competing endogenous RNA network (ceRNET) in ischemic cascade. LncRNA H19/miR-21/PDCD4 ceRNET can directly regulate I/R-induced sterile inflammation and neuronal lesion in vivo. We thus propose that lncRNA-H19 is a previously unknown danger signals in the molecular and immunological pathways of I/R injury, and pharmacological approaches to inhibit H19 seem likely to become treatment modalities for patients in the near future based on these mechanistic findings.
科研通智能强力驱动
Strongly Powered by AbleSci AI